Agency for Defense Development

Intelligent Synthetic Biology Center

Chul Hee Choi

Ju Hyung Lee

Eun Soo Kim

Jin Gang Hou

Seung Wook Ryu

Kyung Sun Choi

Seung Ho Kim

Hyeok Gyu Choi

Byung Seok Woo

Systems, devices, methods, and instructions for transmitting a signal by an electronic apparatus that include generating transmission data and pseudo-random data corresponding to the transmission data, setting a first pseudo time delay interval for the transmission data and a second pseudo time delay interval for the pseudo-random data, acquiring a data signal for transmitting the transmission data to correspond to the first pseudo time delay interval and a pseudo-random signal for transmitting the pseudo-random data to correspond to the second pseudo time delay interval, and transmitting an overlapping signal including the data signal and the pseudo-random signal.

Operating method of electronic apparatus for transmitting signal and electronic apparatus supporting the same

Disclosed is an operation method of an electronic apparatus assigning power based on a position of a terminal, the method including receiving data transmission requests from a first terrestrial terminal and a second terrestrial terminal, wherein the first terrestrial terminal and the second terrestrial terminal use overlapped frequency resources, and assigning a first transmission power intensity to the first terrestrial terminal and assigning a second transmission power intensity to the second terrestrial terminal based on a position of the first terrestrial terminal and a position of the second terrestrial terminal.

Apparatus for assigning power based on position of terminal and method thereof

The present invention relates to an anticancer adjuvant containing, as an active ingredient, protopanaxadiol (PPD) or a compound-K, which are types of panaxadiol ginsenoside compounds, and a pharmaceutical composition for treating cancer containing the anticancer adjuvant and an anticancer agent having mitochondria-mediated anticancer activity. The anticancer adjuvant containing the PPD or compound-K provided in the present invention as an active ingredient damages mitochondria in cancer cells, thereby aiding mitochondria-mediated anticancer activity, and thus can be widely used in safer treatment or alleviation of cancer using anticancer agents that exhibit mitochondria-mediated anticancer activity.

Anticancer adjuvant containing panaxadiol ginsenocide compound

The present invention is directed to a method for screening a regulator of mitochondrial fission using a cell treated to a protopanaxadiol (PPD)-type ginsenoside compound, a composition therefor, and a kit comprising the composition. As the use of the method for screening the regulator of mitochondrial fission of the present invention enables effective discovery of a formulation capable of preventing, improving, or treating a mitochondria-related disease, the method will be widely used for the development of a therapeutic agent for the mitochondria-related disease.

Growing community of inventors

Daejeon, South Korea

Chul Hee Choi